Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities Dafin F. MuresanuStefan StrilciucAdina Stan Current Opinion 11 September 2019 Pages: 841 - 847
Transdermal Delivery of Antipsychotics: Rationale and Current Status Angela AbruzzoTeresa CerchiaraFederica Bigucci Leading Article 06 September 2019 Pages: 849 - 865
Recent Advances in the Drug Treatment of Dravet Syndrome Elaine C. WirrellRima Nabbout Review Article 23 September 2019 Pages: 867 - 881
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases Luke McAlarySteven S. PlotkinNeil R. Cashman REVIEW ARTICLE Open access 14 August 2019 Pages: 883 - 904
Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations Federico CarboneAtbin DjamshidianWerner Poewe Review Article Open access 31 August 2019 Pages: 905 - 918
An Integrated Safety Analysis of Infants and Children with Symptomatic Spinal Muscular Atrophy (SMA) Treated with Nusinersen in Seven Clinical Trials Basil T. DarrasMichelle A. FarrarSarah Gheuens Original Research Article Open access 16 August 2019 Pages: 919 - 932
Subjective Versus Objective Outcomes of Antipsychotics for the Treatment of Neuropsychiatric Symptoms Associated with Dementia Eline J. VredeveldTessa A. HulshofHendrika J. Luijendijk Original Research Article Open access 31 August 2019 Pages: 933 - 942